BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

GlycoMimetics, Inc. 

14915 Broschart Road, Suite 200

Rockville   Maryland  20850  U.S.A.
Phone: 301-738-1166 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
GlycoMimetics, Inc. (GLYC) To Present At The Jefferies and Co. 2015 Healthcare Conference 5/28/2015 11:24:21 AM
GlycoMimetics, Inc. (GLYC) Initiates Phase I/II Clinical Trial Of GMI-1271 As Potential Treatment For Acute Myeloid Leukemia In Combination With Chemotherapy 5/19/2015 12:42:26 PM
GlycoMimetics, Inc. (GLYC) Initiates Phase I/II Clinical Trial Of GMI-1271 As Potential Treatment For Acute Myeloid Leukemia In Combination With Chemotherapy 5/19/2015 11:27:23 AM
FDA Grants Orphan Drug Designation To GlycoMimetics, Inc. (GLYC)’ GMI-1271 For Treatment Of Acute Myleogenous Leukemia (AML) 5/14/2015 10:59:57 AM
GlycoMimetics, Inc. (GLYC) Reports First Quarter 2015 Results 5/6/2015 11:52:25 AM
GlycoMimetics, Inc. (GLYC) Provides Update On Pfizer (PFE)’s Plans To Initiate Phase 3 Trial With Rivipansel In Mid-2015 4/7/2015 9:48:11 AM
GlycoMimetics, Inc. (GLYC) To Present First Preclinical Data On E-Selectin-CXCR4 Dual Antagonist For Cancer Indications At American Association for Cancer Research Annual Meeting 2015 3/19/2015 11:38:26 AM
GlycoMimetics, Inc. (GLYC) Reports Fourth Quarter And Year-End 2014 Results 3/17/2015 11:47:41 AM
GlycoMimetics, Inc. (GLYC) Announces Publication Of Phase 2 Data For Rivipansel In Sickle Cell Disease 3/3/2015 10:23:23 AM
GlycoMimetics, Inc. (GLYC) To Present At Two Investor Conferences In March 2/26/2015 12:14:06 PM
123456789